The EdU staining assays also demonstrated that PARP1 and HIF-1a could reverse the impact of SKA3 on the proliferation of CCA cells under hypoxic conditions (Supplementary 12D). The gene discussed is HIF1A; the disease is cholangiocarcinoma.